These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 8843284)
1. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Vaara M; Porro M Antimicrob Agents Chemother; 1996 Aug; 40(8):1801-5. PubMed ID: 8843284 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Viljanen P; Vaara M Antimicrob Agents Chemother; 1984 Jun; 25(6):701-5. PubMed ID: 6331296 [TBL] [Abstract][Full Text] [Related]
3. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. Tsubery H; Ofek I; Cohen S; Fridkin M J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216 [TBL] [Abstract][Full Text] [Related]
4. The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Tsubery H; Ofek I; Cohen S; Fridkin M Biochemistry; 2000 Oct; 39(39):11837-44. PubMed ID: 11009595 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741. Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232 [TBL] [Abstract][Full Text] [Related]
6. Membrane-disorganizing property of polymyxin B nonapeptide. Lam C; Hildebrandt J; Schütze E; Wenzel AF J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982 [TBL] [Abstract][Full Text] [Related]
7. [The action of combinations of the nonapeptide polymyxin B with antibiotics on gram-negative bacteria]. Bairamashvili DI; Zinchenko AA; Maslin DN; Trakhanova MN; Miroshnikov AI Antibiot Khimioter; 1988 Aug; 33(8):591-4. PubMed ID: 2848467 [TBL] [Abstract][Full Text] [Related]
8. Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics. Baker KR; Jana B; Hansen AM; Nielsen HM; Franzyk H; Guardabassi L Front Cell Infect Microbiol; 2019; 9():236. PubMed ID: 31334131 [TBL] [Abstract][Full Text] [Related]
9. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide. Vaara M Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436 [TBL] [Abstract][Full Text] [Related]
10. Polycations sensitize enteric bacteria to antibiotics. Vaara M; Vaara T Antimicrob Agents Chemother; 1983 Jul; 24(1):107-13. PubMed ID: 6414364 [TBL] [Abstract][Full Text] [Related]
11. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Vaara M Antimicrob Agents Chemother; 1993 Feb; 37(2):354-6. PubMed ID: 8383945 [TBL] [Abstract][Full Text] [Related]
12. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City. Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342 [TBL] [Abstract][Full Text] [Related]
13. Sodium hexametaphosphate sensitizes Pseudomonas aeruginosa, several other species of Pseudomonas, and Escherichia coli to hydrophobic drugs. Vaara M; Jaakkola J Antimicrob Agents Chemother; 1989 Oct; 33(10):1741-7. PubMed ID: 2511800 [TBL] [Abstract][Full Text] [Related]
14. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice. Ofek I; Cohen S; Rahmani R; Kabha K; Tamarkin D; Herzig Y; Rubinstein E Antimicrob Agents Chemother; 1994 Feb; 38(2):374-7. PubMed ID: 8192470 [TBL] [Abstract][Full Text] [Related]
15. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Vaara M; Siikanen O; Apajalahti J; Fox J; Frimodt-Møller N; He H; Poudyal A; Li J; Nation RL; Vaara T Antimicrob Agents Chemother; 2010 Aug; 54(8):3341-6. PubMed ID: 20479195 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin. Finland M; Garner C; Wilcox C; Sabath LD J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection]. Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068 [TBL] [Abstract][Full Text] [Related]
18. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Vaara M; Fox J; Loidl G; Siikanen O; Apajalahti J; Hansen F; Frimodt-Møller N; Nagai J; Takano M; Vaara T Antimicrob Agents Chemother; 2008 Sep; 52(9):3229-36. PubMed ID: 18591267 [TBL] [Abstract][Full Text] [Related]
19. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China]. Chen MJ; Wang H; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912 [TBL] [Abstract][Full Text] [Related]
20. A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli. Baker KR; Jana B; Franzyk H; Guardabassi L Antimicrob Agents Chemother; 2016 Oct; 60(10):5995-6002. PubMed ID: 27458225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]